Literature DB >> 3082151

MR imaging of prolactin-secreting microadenomas.

K W Pojunas, D L Daniels, A L Williams, V M Haughton.   

Abstract

Eight proven and three presumed prolactin-secreting microadenomas were studied with magnetic resonance (MR) imaging. All 11 cases had CT evidence of a tumor. Technical factors for MR included use of 1.3-1.5 T MR systems, 3 mm slice thickness, short repetition time (TR) (T1-weighted) and long TR (T2-weighted) spin-echo pulse sequences. Six microadenomas were demonstrated with MR. Four tumors had a long T1 and long T2, one had a long T1 and short T2, and one bromocriptine-treated tumor had a short T1 and short T2. MR failed to delineate the focal mass within the pituitary gland in the other five patients. The cause of the MR failures was not determined; however, tumor size did not appear to be a factor. MR signals arising from microadenomas are variable and possibly related to the activity of the prolactin-secreting cells. Correlation of findings from MR imaging, spectroscopy, and electron microscopy may lead to an understanding of the variable MR appearance of microadenomas.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082151      PMCID: PMC8332680     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  12 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Contrast behavior between microadenoma and normal pituitary gland after gadolinium injection as a function of time at 1.5 T.

Authors:  T Stadnik; A Stevenaert; A Beckers; D Van Herzele; R Luypaert; T Buisseret; M Osteaux
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

3.  Towards an advisor for MRI.

Authors:  G H du Boulay; A J Woods; D Teather; B A Teather; K M Wills; D Plummer
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

4.  3D-FT thin sections MRI of prolactin-secreting pituitary microadenomas.

Authors:  N Girard; T Brue; V Chabert-Orsini; C Raybaud; P Jaquet; M Poncet; F Grisoli; S Cahen
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

5.  Pituitary microadenomas. Does Gadolinium enhance their demonstration?

Authors:  P Macpherson; D M Hadley; E Teasdale; G Teasdale
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

Review 6.  Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.

Authors:  Amy Yao; Priti Balchandani; Raj K Shrivastava
Journal:  World Neurosurg       Date:  2017-04-28       Impact factor: 2.104

7.  Haemorrhagic pituitary tumours.

Authors:  C M Lazaro; W Y Guo; M Sami; T Hindmarsh; K Ericson; A L Hulting; J Wersäll
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

8.  Disappearance of a pituitary tumor after 15 months of treatment with CV 205-502, a new dopamine agonist.

Authors:  W J Fassbender; H Stracke; G Bachmann; W Rau; K Federlin
Journal:  Clin Investig       Date:  1992-05

Review 9.  Magnetic resonance imaging of the brain and spine.

Authors:  D M Hadley; G M Teasdale
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

10.  MRI of pituitary adenomas: the position of the normal pituitary gland.

Authors:  M Sumida; T Uozumi; K Mukada; K Arita; K Kurisu; T Yano; J Onda; H Satoh; F Ikawa
Journal:  Neuroradiology       Date:  1994-05       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.